๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

A preliminary study on the possible role for luetinizing hormone in androgen independent growth of prostate

โœ Scribed by V Sriraman; Veena S Rao; N Rajesh; S.S. Vasan; AJ Rao

Book ID
119611249
Publisher
Reproductive Healthcare Ltd
Year
2001
Tongue
English
Weight
458 KB
Volume
3
Category
Article
ISSN
1472-6491

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Constitutive activation of the androgen
Constitutive activation of the androgen receptor by a point mutation in the hinge region: A new mechanism for androgen-independent growth in prostate cancer
โœ Jocelyn Cรฉraline; Marion D. Cruchant; Eva Erdmann; Philippe Erbs; Jean-Emmanuel ๐Ÿ“‚ Article ๐Ÿ“… 2003 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 278 KB ๐Ÿ‘ 2 views

## Abstract Androgen receptor (AR) mutations that modify both the ligand binding and the transactivation capacities of the AR represent one of the mechanisms involved in the transition of prostate cancer (PCa) from androgenโ€dependent to androgenโ€independent growth. We use a yeastโ€based functional a

Growth-inhibitory effects of luteinizing
Growth-inhibitory effects of luteinizing hormone-releasing hormone (LHRH) agonists on xenografts of the DU 145 human androgen-independent prostate cancer cell line in nude mice
โœ Donatella Dondi; Roberta M. Moretti; Marina Montagnani Marelli; Graziella Prates ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 131 KB ๐Ÿ‘ 2 views

Experiments have been performed to clarify whether LHRH agonists might decrease growth of hormone-unresponsive prostate cancer in vivo. Male nude mice were injected s.c. with the human androgen-independent prostate tumor DU 145 cells; osmotic minipumps releasing the LHRH agonist Zoladex (LHRH-A) for